logo-loader
RNS
Barclays PLC

FORM 38.5(b)-OSMOTICA PHARMACEUTICALS PLC

--(BUSINESS WIRE)--LONDON 

Ap27

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

2. INTERESTS ANDSHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Ap28

3. DEALINGS (Note 3)

a. Purchases and sales

b. Derivatives transactions (other than options transactions)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

ii. Exercising

d. Other dealings (including transactions in respect of new securities) (Note 3)

Ap29

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

 

BARCLAYS PLC

Source: BARCLAYS PLC

Name of exempt principal trader:BARCLAYS CAPITAL INC
Company dealt inOSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which theordinary sharesUS$0.01
dealings being disclosed relate
Date of dealing17 February 2021
Class of relevant security:

ORD

 

 

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

320

0.00%

0

0.00%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

0

0.00%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

320

0.00%

0

0.00%

 

 

 

 

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Purchase/sale

Number of

Price per unit

securities

 

Purchase

8

4.4700 USD

Sale

8

4.4700 USD

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

 

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Is a Supplemental Form 38.5(b) attached?

NO

Date of disclosure:

18 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Name of offeree/offeror with which connected

 

Nature of connection

 

NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

8 hours, 3 minutes ago

Form 8.3 SPIRE HEALTHCARE GROUP PLC

9 hours, 18 minutes ago

Form 8.3 SEGRO PLC

9 hours, 37 minutes ago

Form 8.3 MOBICO GROUP PLC

10 hours, 16 minutes ago

Form 8.3 PROLOGIS, INC.

10 hours, 17 minutes ago

Form 8.3 STHREE PLC

10 hours, 17 minutes ago

Form 8.3 TATE & LYLE PLC

10 hours, 17 minutes ago

Form 8.5 EPT/Non RI EASYJET PLC

11 hours, 5 minutes ago

2 min read